+36.1%
MRNA vs VRSN
+44.6%
-8.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VRSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.3% | +4.0% | +5.4% |
| 7D | -1.1% | +0.2% | -1.3% | -1.1% |
| 30D | +126.1% | +3.8% | +122.4% | +126.9% |
| 3M | +190.0% | +5.0% | +185.0% | +189.8% |
| 6M | +157.2% | +24.9% | +132.4% | +145.6% |
| YTD | +388.2% | +21.6% | +366.6% | +367.9% |
| 1Y | +467.0% | +2.4% | +464.6% | +466.0% |
| 3Y | +36.1% | +47.3% | -11.3% | +16.2% |
| All | +36.1% | +44.6% | -8.5% | +16.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSN.
Daily Out/Under-Performance
Portfolio return minus VRSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling